nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Aztreonam—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Aztreonam—Dysgeusia—Lisinopril—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Aztreonam—Discomfort—Leflunomide—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Aztreonam—Cough—Mycophenolic acid—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Aztreonam—Vomiting—Pentoxifylline—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Aztreonam—Convulsion—Mycophenolic acid—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Aztreonam—Rash—Pentoxifylline—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Aztreonam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Aztreonam—Headache—Pentoxifylline—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Aztreonam—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Aztreonam—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Aztreonam—Feeling abnormal—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Aztreonam—Myalgia—Mycophenolic acid—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Aztreonam—Chest pain—Mycophenolic acid—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Aztreonam—Gastrointestinal pain—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Aztreonam—Asthenia—Mometasone—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Aztreonam—Hypotension—Azathioprine—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Aztreonam—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Aztreonam—Discomfort—Mycophenolic acid—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Aztreonam—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Aztreonam—Pruritus—Mometasone—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Aztreonam—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Aztreonam—Anaemia—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Aztreonam—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Aztreonam—Angioedema—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Aztreonam—Confusional state—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Aztreonam—Abdominal pain—Captopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Aztreonam—Body temperature increased—Captopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Aztreonam—Nausea—Pentoxifylline—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Aztreonam—Malaise—Lisinopril—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Aztreonam—Vertigo—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Aztreonam—Diarrhoea—Mometasone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Aztreonam—Hypotension—Leflunomide—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Aztreonam—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Aztreonam—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Aztreonam—Cough—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Aztreonam—Insomnia—Leflunomide—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Aztreonam—Abdominal distension—Prednisone—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Aztreonam—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Aztreonam—Paraesthesia—Leflunomide—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Aztreonam—Chest pain—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Aztreonam—Myalgia—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Aztreonam—Dyspnoea—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Aztreonam—Hypotension—Mycophenolic acid—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Aztreonam—Discomfort—Lisinopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Aztreonam—Vomiting—Mometasone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Aztreonam—Sweating increased—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Aztreonam—Feeling abnormal—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Aztreonam—Rash—Mometasone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Aztreonam—Asthenia—Captopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Aztreonam—Dermatitis—Mometasone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Aztreonam—Confusional state—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Aztreonam—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Aztreonam—Headache—Mometasone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Aztreonam—Insomnia—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Aztreonam—Anaphylactic shock—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Aztreonam—Pruritus—Captopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Aztreonam—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Aztreonam—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Aztreonam—Pain—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Aztreonam—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Aztreonam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Aztreonam—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Aztreonam—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Aztreonam—Neutropenia—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Aztreonam—Abdominal pain—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Aztreonam—Body temperature increased—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Aztreonam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Aztreonam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Aztreonam—Diarrhoea—Captopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Aztreonam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Aztreonam—Feeling abnormal—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Aztreonam—Nausea—Mometasone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Aztreonam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Aztreonam—Pain—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Aztreonam—Cough—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Aztreonam—Hypotension—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Aztreonam—Dizziness—Captopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Aztreonam—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Aztreonam—Urticaria—Leflunomide—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Aztreonam—Abdominal pain—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Aztreonam—Body temperature increased—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Aztreonam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Aztreonam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Aztreonam—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Aztreonam—Hypersensitivity—Azathioprine—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Aztreonam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Aztreonam—Insomnia—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Aztreonam—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Aztreonam—Paraesthesia—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Aztreonam—Vomiting—Captopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Aztreonam—Dyspnoea—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Aztreonam—Rash—Captopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Aztreonam—Dermatitis—Captopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Aztreonam—Headache—Captopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Aztreonam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Aztreonam—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Aztreonam—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Aztreonam—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Aztreonam—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Aztreonam—Hypersensitivity—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Aztreonam—Pain—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Aztreonam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Aztreonam—Diarrhoea—Azathioprine—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Aztreonam—Haemoglobin—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Aztreonam—Nausea—Captopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Aztreonam—Haemorrhage—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Aztreonam—Asthenia—Leflunomide—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Aztreonam—Feeling abnormal—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Aztreonam—Pruritus—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Aztreonam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Aztreonam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Aztreonam—Dizziness—Azathioprine—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Aztreonam—Asthenia—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Aztreonam—Diarrhoea—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Aztreonam—Urticaria—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Aztreonam—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Aztreonam—Body temperature increased—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Aztreonam—Abdominal pain—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Aztreonam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Aztreonam—Pruritus—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Aztreonam—Vomiting—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Aztreonam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Aztreonam—Rash—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Aztreonam—Dermatitis—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Aztreonam—Flushing—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Aztreonam—Headache—Azathioprine—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Aztreonam—Dizziness—Leflunomide—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Aztreonam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Aztreonam—Pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Aztreonam—Vomiting—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Aztreonam—Hypersensitivity—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Aztreonam—Dizziness—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Aztreonam—Rash—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Aztreonam—Dermatitis—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Aztreonam—Nausea—Azathioprine—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Aztreonam—Headache—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Aztreonam—Erythema—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Aztreonam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Aztreonam—Asthenia—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Aztreonam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Aztreonam—Pruritus—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Aztreonam—Vomiting—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Aztreonam—Rash—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Aztreonam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Aztreonam—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Aztreonam—Headache—Mycophenolic acid—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Aztreonam—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Aztreonam—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Aztreonam—Nausea—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Aztreonam—Diarrhoea—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Aztreonam—Ill-defined disorder—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Aztreonam—Anaemia—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Aztreonam—Angioedema—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Aztreonam—Dizziness—Lisinopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Aztreonam—Nausea—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Aztreonam—Malaise—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Aztreonam—Vertigo—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Aztreonam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Aztreonam—Vomiting—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Aztreonam—Rash—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Aztreonam—Convulsion—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Aztreonam—Dermatitis—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Aztreonam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Aztreonam—Headache—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Aztreonam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Aztreonam—Myalgia—Prednisone—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Aztreonam—Discomfort—Prednisone—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Aztreonam—Erythema—Methotrexate—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Aztreonam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Aztreonam—Nausea—Lisinopril—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Aztreonam—Anaphylactic shock—Prednisone—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Aztreonam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000926	0.000926	CcSEcCtD
Aztreonam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000902	0.000902	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Aztreonam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Aztreonam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Aztreonam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Aztreonam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Aztreonam—Malaise—Methotrexate—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Aztreonam—Insomnia—Prednisone—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Aztreonam—Paraesthesia—Prednisone—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Aztreonam—Cough—Methotrexate—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Aztreonam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Aztreonam—Feeling abnormal—Prednisone—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Aztreonam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000776	0.000776	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Aztreonam—Urticaria—Prednisone—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Aztreonam—Abdominal pain—Prednisone—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Aztreonam—Body temperature increased—Prednisone—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Aztreonam—Hypersensitivity—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Aztreonam—Asthenia—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Aztreonam—Pain—Methotrexate—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Aztreonam—Pruritus—Prednisone—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Aztreonam—Diarrhoea—Prednisone—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Aztreonam—Dizziness—Prednisone—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Aztreonam—Vomiting—Prednisone—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Aztreonam—Rash—Prednisone—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Aztreonam—Dermatitis—Prednisone—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Aztreonam—Headache—Prednisone—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Aztreonam—Nausea—Prednisone—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Aztreonam—Rash—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Aztreonam—Headache—Methotrexate—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Aztreonam—Nausea—Methotrexate—systemic scleroderma	0.000471	0.000471	CcSEcCtD
